PTI-125-10: An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability of Simufilam 100mg Tablets in Participants with Mild to Moderate Alzheimer#s Disease

Grants and Contracts Details

StatusActive
Effective start/end date2/19/242/19/26

Funding

  • Premier Research International LLC: $5,932.00